Minneapolis, Minnesota, U.S.A. (7 December, 2018) – IMRIS, Deerfield Imaging, the global leader in intraoperative MRI, announced today that Prince Sultan Military Medical City (hereafter referred to as ‘PSMMC’), in collaboration with distributor Gulf Medical Company, signed a formal agreement to install the first IMRIS Surgical Theatre in Saudi Arabia. Construction at the PSMMC site is currently underway, with anticipated completion in late 2019.
The IMRIS Surgical Theatre uniquely provides intraoperative imaging by transporting the MR scanner between rooms on a ceiling-mounted rail system. At PSMMC, the new IMRIS Surgical Theatre will be a two-room configuration — one room for surgery and the other for diagnostic scanning for outpatient needs. The scanner travels directly to the patient while the patient remains stationary on the operating table. Keeping the patient stationary reduces the risk of infection. With real-time visualization of the anatomy, neurosurgeons can evaluate their progress and confirm results, which reduces the need for follow-up surgeries. Intraoperative imaging also enables neurosurgeons to use perform minimally-invasive procedures, such as deep brain stimulation (DBS) and laser interstitial thermal therapy (LITT).
Formerly known as Riyadh Military Hospital, PSMMC is located in the heart of Riyadh City, the capital of Saudi Arabia. It is considered to be one of the most advanced medical centers in the Middle East. PSMMC is the Medical Services Department (MSD) of the Ministry of Defense and Aviation (MODA). Gulf Medical Company is one of the largest distributors in Saudi Arabia, and has vast experience working with medical device companies for large, turnkey hospital projects like the IMRIS Surgical Theatre at PSMMC.
“We enthusiastically look forward to this upcoming project that will definitely act as a cornerstone for a new era for IMRIS in the kingdom of Saudi Arabia,” said Emad M. Farid, Area Manager, Central Region – KSA for Gulf Medical Company.”
Minneapolis, Minn. (December 3, 2018) – IMRIS, Deerfield Imaging, global leader in the hybrid OR market, today announced entry into the stroke market with a global distribution agreement to sell VasSol, Inc.’s NOVA® Quantitative MRA software.
Every year, over 900,000 Americans experience a stroke or transient ischemic attack (TIA) caused by insufficient blood flow to the brain. Known as an ischemic stroke, it is the most common type of stroke and the leading cause of disability in the United States. The high risk of recurrence in stroke survivors is a major public health concern.
NOVA Quantitative MRA is a powerful diagnostic tool that gives stroke specialists the ability to quantify cerebral hemodynamics and to help assess risk of stroke. NOVA-Neuro is the first commercially available software to use a 3D model-based approach for MR flow measurement.
“NOVA is a powerful tool that provides critical information impacting the care and treatment of patients who have compromised cerebral vascular blood flow which can be life threatening. This partnership with IMRIS will put NOVA in the hands of more hospitals and clinicians around the world so they can treat their patients more effectively,” said Dr. Fady T. Charbel, Professor and Head of the Department of Neurosurgery at University of Illinois, Chicago. Dr. Charbel is an internationally recognized clinical expert in cerebral revascularization; bypass, carotid, and vertebral artery surgery; and a co-inventor and developer of NOVA.
For the past 20 years, similar clinical applications have made phase contrast MR flow measurement the standard of care in cardiovascular MRI. Now NOVA provides neurosurgeons and neuroradiologists this essential tool to apply those same principles to quantitative flow measurements in cerebral vasculature.
“IMRIS is excited to bring this impactful technology to the market and to our expanding global customer base. IMRIS is uniquely positioned in this market segment to help positively impact patient outcomes with the NOVA technology based on our organization’s expertise in both MRI and the neurosciences,” said Robert Korn, Senior Vice President of Global Sales and Marketing for IMRIS.
Unique solution for MR scanner will be first of its kind
Minneapolis, Minn., (November 26, 2018) – IMRIS, Deerfield Imaging, global leaders in the hybrid operating room market, announced today that Memorial Sloan Kettering Cancer Center signed a formal agreement to design and build a new IMRIS Surgical Theatre at their New York City location. Memorial Sloan Kettering is planning to upgrade their existing intraoperative MRI suite. Construction will begin in February 2019, with anticipated completion in July 2020.
The new IMRIS Surgical Theatre at Memorial Sloan Kettering will be a two-room configuration – an operating room and an adjacent room to house the new MR scanner. The scanner will travel between the two rooms on a ceiling-mounted rail system.
The biggest challenge was to design a state-of-art IMRIS Surgical Theatre, complete with ceiling-mounted moving MR scanner, within the footprint of the existing MRI suite. IMRIS software engineers met this challenge by developing a software program to accommodate rotation of the MR scanner. Upon command, the scanner will rotate into linear position, and then move into the operating room to scan patients during surgery.
The intraoperative imaging suite at Memorial Sloan Kettering will be the first of its kind – an example of how IMRIS consults with their customers to design innovative solutions to work around the unique challenges at each institution.
IMRIS provides intraoperative imaging by transporting the MR scanner between rooms. The scanner travels to the patient while the patient remains stationary on the operating table. Keeping the patient stationary reduces the risk of infection and other potential complications. With real-time visualization of the anatomy, neurosurgeons can evaluate their progress and confirm results, which reduces the need for follow-up surgeries. Intraoperative imaging also enables neurosurgeons to perform minimally-invasive procedures such as deep brain stimulation (DBS) and laser interstitial thermal therapy (LITT).
At this year’s Congress of Neurological Surgeons annual meeting, IMRIS is looking to the future.
What happens when global innovators unite?
We’re unveiling two groundbreaking partnerships, opening new possibilities for the world’s neurosurgical community. Meet our representatives at CNS to learn more.
How is hybrid technology changing outcomes?
Intraoperative MRI, CT and Angio modalities are helping neurosurgeons around the world achieve better outcomes. Connect with IMRIS at CNS to discover our role as consultants, designers, creators and supporters of the hybrid OR.
What happens when technology meets humanity?
We are the global leaders of hybrid technology, bringing together skilled individuals, groundbreaking innovation, and industry partnerships to create the world’s most advanced hybrid surgical theatres. See what happens next at CNS.
Peter Simpson, a leading medical innovator, has joined IMRIS as Senior Vice President of Research and Development. For a quick recap of his career and a description of Simpson’s new role, see A Leading Industry Innovator Joins IMRIS R&D.
After developing and launching technologies at the world’s leading innovators – from start-up shops in the heart of Silicon Valley to major healthcare providers in China, India, Brazil and beyond – Peter Simpson is still driven by the reason he became an engineer in the first place: people.
A Philosophy Rooted in Silicon Valley
It began with a paradox, an unexpected lesson at Stanford University, where Simpson studied Mechanical Engineering and Product Design. There, he learned to begin with the end: to start with the needs of the end-user and work backwards – creating a product that doesn’t just function, but fundamentally changes the way people live.
“It’s easy to get bogged down in the technical details of a product: the regulations, the functionality, the system around it,” Simpson says. “Those things are important, but they aren’t the starting point. “It seems obvious, but accounting for human need is fundamental to the success of a product. You have to remember why you’re doing what you’re doing – and build from there.”
He had the fundamentals of a philosophy that would define his career, and in 1982, he brought his signature “human-first approach” to Silicon Valley, a region in the San Francisco Bay area that was just beginning to emerge as the technological boomtown it would later become. It worked; but it forced Simpson to adapt, in the process. The pressure chamber of small, fast-paced start-ups pushed him to adopt a new mentality toward product development: to be system-minded, rather than just product-minded.
It wasn’t enough to design a strong product that people wanted. To properly develop and launch these new technologies, he had to manage all the logistical challenges that accompany development. In addition to technical design, Simpson would research the optimal materials, manage the intricate details of assembly, and work with a network of companies across the globe to learn and perfect the manufacturing pipeline. “I enjoyed that, the chance to be a part of everything… to learn how engineering is an integral part of creating not only a product, but a business.”
As he honed his leadership skills and discovered opportunities in emerging markets, that experience took Simpson far beyond the Valley.
Beyond The Valley:
A Decade of Global Innovation
For many successful, respected engineering careers, Silicon Valley is the peak. For Simpson, it was more a launch pad. After departing the Valley, Simpson joined a product-development firm in Chicago. For more than a decade, he created products for a vast array of industries: designing, developing, and launching consumer goods for companies like PepsiCo, crafting high-speed innovations for aerospace clients, mastering the product-development process, working at the speed of a Silicon start-up under the expectations of a global company, perfecting his leadership skills, tackling a constant stream of challenges, opportunities and surprises – and, along the way, modifying his approach while holding steadfast to his core philosophy.
During that decade of innovation, Simpson explored product development in many industries – with products that couldn’t be more different. Still, as he worked through nuanced challenges and discovered familiar patterns along the way, Simpson found a common thread that ties together all product-development projects – from soft drinks to spacecraft.
“It’s always about the end-user. Every industry has its particular products, but the successful ones are always driven, first and foremost, by what the user needs,” says Simpson, who helped the Chicago development firm grow from 180 employees to more than 400.
In the mid-2000’s, that user-centric mentality brought Simpson to the forefront of global healthcare, where he discovered an industry where human-first innovation is always in high demand.
Finding Humanity in Healthcare
A fundamental rule of product development is that functionality alone is never enough. A product can’t just work; it has to be something people will use. As Simpson developed products for major healthcare providers across the globe – everything from dialysis machines and infusion pumps to sleep apnea-treatment devices and imaging modalities – the needs of the end-user always drove the design.
“The human side makes a huge difference,” says Simpson. “If you don’t design the product to be easy-to-use, if it doesn’t make sense in real life, people just won’t use it. Before you get to the technical, you have to account for the emotional and social aspects of design.”
At Philips, Simpson led R&D for the X-Ray business unit in Germany and the MR Advanced Clinical Solutions Team in the United States – using the ‘human side of design’ to influence every product, from the macro “big ideas” to the micro details. Before he ever considered the technical side of the imaging modalities, Simpson would audit the patients and radiologists who depend on the systems, using their feedback to inform every element of product design. The result was effective technological innovation that improved outcomes in hospitals all over the world.
With success in X-Ray and MRI, Simpson’s career was becoming increasingly focused on imaging modalities. Meanwhile, “intraoperative imaging” was emerging as the future of the industry. Intraoperative imaging brings imaging modalities – like MRI, CT and Angio – into the surgical environment, creating a “hybrid” surgical theatre. This empowers surgeons to obtain real-time images of their patient mid-operation, offering an ‘inside look” that, until recently, was impossible. For patients, that means better outcomes and the opportunity for new, minimally invasive procedures.
Simpson saw the potential of intraoperative imaging. The hybrid OR was the OR of the future. And, at the forefront of the industry, there was IMRIS, the global leader of intraoperative imaging and hybrid surgical theatre design. In IMRIS, Simpson saw a unique opportunity: a team with the potential of a global leader and the energy of a Silicon Valley start-up, reminiscent of the companies that launched a young engineer’s career in 1982.
Bringing a Personal Approach to IMRIS R&D
Today, Simpson has joined IMRIS as the Vice President of Research and Development, where he’s channeling his human-first, system-minded approach into industry-leading innovation.
Simpson’s aspirations are groundbreaking at a global scale: He plans to use every lesson he learned from decades of product development to lead IMRIS down bold new roads – as both an innovator and a leader, creator and aggregator, a company that brings together disparate technologies into cohesive systems centered on the human experience. Still, for Simpson, who always considers the people impacted by his work, R&D is always personal.
“Everything we do here, every piece of technology, I want to design it as if my wife or my child is going to depend on it,” says Simpson, whose family members have, in fact, been imaged by devices he helped design. “That’s always in the back of my mind. It helps me perform at my best, when I know what’s on the table.”
As IMRIS’ Customer Service offering revolutionizes surgical theatre support, four new staff members are bringing decades of technical experience to the team.
We’re offering a holistic service solution for the hybrid OR, a comprehensive package that no other company has provided – until now. These new staff members further expand our support capabilities, so we can continue to deliver on our promise of an unparalleled intraoperative experience. Each of them is essential to our mission.
A NEW VP OF GLOBAL CUSTOMER SERVICE
Kristi Timmer joined IMRIS as VP, Global Customer Service, bringing over 20 years of operations and technical services leadership within the medical device industry and healthcare.
Kristi will help IMRIS continue to build upon our current successes and lead us through key improvement opportunities. Kristi is an accomplished professional who brings strong leadership and industry experience to IMRIS.
NEW CUSTOMER SERVICE ENGINEERS
Gregory Stewart and Bobby Edwards joined IMRIS as Customer Service Engineers, bringing a wide array of technical & communication skills, as well as deep field-service experience on linear accelerators (a major component of radiology/imaging modalities).
ABOUT IMRIS CUSTOMER SUPPORT & SERVICE
As part of our comprehensive Customer Support & Service, IMRIS offers on-site support – available at all times to resolve technical issues and maximize the uptime of your IMRIS Surgical Theatre.
Our 24/7 Customer Support number is available for reporting issues and for troubleshooting assistance. If you need onsite assistance, an IMRIS Customer Service Engineer will be dispatched to your site.
As part of your service contract, you will receive the following support:
An IMRIS Customer Service Engineer assigned to your site
Uptime performance guarantee
Planned Maintenance (PM) Service
Scheduled servicing on all covered equipment
Onsite response time in hours, depending on your service level
Principle Coverage Period (PCP)
The option to select extended equipment coverage for all third-party equipment
Bringing vast experience as an innovator in the medical device industry, Peter Simpson has joined IMRIS as Senior Vice President of Research & Development.
For more than 13 years, Simpson has delivered innovative, successful products at benchmark technological organizations, including Baxter, Covidien, and Philips, where he held several leadership roles within the diagnostic imaging business units.
“Innovation is at the core of our mission,” says IMRIS President and CEO, Andy Flanagan.
“Peter has the experience, the energy and the skillset to deliver innovative products that revolutionize the surgical environment. Most importantly, he understands the IMRIS mission: elevating the patient experience. He’s committed to delivering products that meet our goals and drive our mission forward.”
Simpson, who has developed products in healthcare, consumer goods, and even aerospace engineering, strives to balance technical ingenuity with user-first design.
“Human need is at the center of product development,” Simpson says. “IMRIS is all about doing what’s best for people – patients, surgeons, families. That’s going to continue to be the driving force of IMRIS R&D.”
PETER SIMPSON, CAREER HIGHLIGHTS:
Simpson has held leadership roles at Baxter, Covidien, and Philips.
His work has focused on cross-functional development and business line portfolio management processes in multiple industries and businesses.
At Philips, Simpson led R&D for the X-ray business unit from Hamburg, Germany and the MR Advanced Clinical Solutions team in the United States. He also co-founded and led R&D for the Radiology Solutions business unit.
In his most recent assignment – as Sr. Director of the Diagnostic Imaging Idea-to-Market Team at Philips – Simpson was responsible for improving strategic customer engagement, diagnostic imaging business positioning, and critical product quality improvements.
Simpson earned his Bachelor’s degree in Mechanical Engineering and Product Design at Stanford University.
At this year’s biggest neurosurgery conference, the AANS Annual Scientific Meeting, more than 3,000 neurosurgeons, innovators and industry leaders gathered in New Orleans to determine the future of neurosurgery.
From the utility of big data to the evolution of the hybrid OR, these innovators answered some of today’s most challenging questions… and offered even more.
Following AANS, these are the top 3 neurosurgery questions on people’s minds:
#1: HOW DOES INFORMATION TRANSLATE INTO BETTER OUTCOMES?
IMRIS is determined to be a leading innovator in neurosurgery-specific information technology. We connect neurosurgeons with actionable data insights, further empowering them during procedures using intraoperative imaging. Now, we’re developing the first clinical and research data-management software tailored to the neurosurgery community.
Medical disciplines are beginning to harness the power of data. Now, that trend has reached neurosurgery. At AANS 2018, one of the biggest questions was:
How are industry leaders aggregating both big data and individual patient information, and implementing it into neurosurgical workflows?
#2: WHAT INNOVATIONS ARE TRANSFORMING THE PATIENT EXPERIENCE?
Leading innovators are redefining the patient experience – driving further innovation and unexpected collaboration. Lower risk, higher confidence and quicker recovery times are the pillars of the modern patient experience. At AANS 2018, industry leaders showcased new technologies that tap into the potential of intraoperative imaging, taking the patient experience to the next level.
Developed in close collaboration with clinicians and engineers from IMRIS and Hill-Rom’s Trumpf Medical, the IMRIS MR Neurosurgical Table is the first MR-conditional table system designed specifically for the hybrid OR environment.
IMRIS’ Premium Clinical Support marks an evolution of customer service. Combining deep knowledge of intraoperative imaging with their clinical expertise, the team provides a comprehensive suite of educational, clinical, and workflow-migration services for IMRIS customers.
#3: HOW DO WE BRING HARMONY TO THE HYBRID OR?
IMRIS is collaborating with leading intraoperative innovators, connecting technology & design into cohesive systems powered by research data & clinical information. Together, we’re bringing harmony to the hybrid OR.
The modern hybrid surgical theatre – which incorporates imaging modalities like MRI, CT and Angio – is a symphony of technology and design. It’s the future of neurosurgery, empowering surgeons to achieve better outcomes and perform minimally invasive procedures via intraoperative imaging. However, to drive better outcomes and elevate the surgical experience, the hybrid theatre requires the integration of many different technologies…and finding harmony among them is both essential to the theatre’s efficacy and it is deeply challenging.
At this year’s AANS conference, IMRIS emerged as an industry aggregator. We’re not focused on a single technology; instead, we’re partnering with industry leaders to elevate the hybrid environment as a whole system, connecting disparate technologies and harnessing the potential of the information flowing within them.
While AANS offered many new questions, it’s clear that not only innovation, but collaboration, is essential to determining the answers and providing solutions. IMRIS is committed to forging these collaborations and driving patient-centric innovation – for the future of neurosurgery and the future of the patient experience.
Your hospital is like no other. No one knows your hospital better than you.
Discover how IMRIS is collaborating with hospital administrators to increase patient-demand, elevate institutional prestige, and bring the Human Experience to your patients and staff.
DEFINING GOALS IN PHASE 1: CONSULT.
We’ll start by outlining your goals – this time, at an institutional level. What’s your vision for the future of your hospital? What are your fiscal objectives? Are you looking to increase patient volume? Elevate your institutional prestige? Outpace your competitors? Establish or solidify your position as a leading neurological institution?
Once we’ve discovered your hospital’s objectives, we’ll work with you to create a custom solution that brings them to life – accounting for all limits: economic, spatial, etc. Then, once we have a strategy that satisfies all stakeholders, we’ll bring together groundbreaking technology and human-centric design as we craft the world’s most advanced hybrid surgical theatre.
PURSUING OPPORTUNITIES IN PHASE 2: DESIGN.
No other hospital has the same configuration, the same goals and the same challenges as yours. We’ll work with you to understand your hospital’s wholly unique situation – from construction limitations and budgetary requirements, to access routes, emergent opportunities and even interdepartmental collaboration.
Then, our team of architects & designers will design the theatre to meet your objectives, while accounting for your challenges along the way.
BUILDING COMMUNICATION IN PHASE 3: CREATE.
Communication is critical to the successful, on-schedule installation of your theatre. To make this possible, we’ve streamlined the Creation process, incorporating all elements, from management to installation, into a comprehensive solution.
We’ll begin by establishing a program manager. They’ll be your central point-of-contact. This creates a strong line of communication between your institution and IMRIS, a bridge that will maximize value, minimize interruption and enable us to deliver a premier Creation experience.
EVOLVING YOUR INSTITUTION IN PHASE 4: SUPPORT.
As your institutional goals evolve, we work with you to evolve your theatre.
Together, we’ll maintain your position at the forefront of the medical industry, open new opportunities for groundbreaking procedures, and introduce industry-shifting innovations that elevates your prestige while increasing your patient-demand.
Our hybrid surgical theatres are as unique as you.
Fully customized to your surgical workflow.
Tailored to meet your institution’s unique objectives.
Supported to maximize your clinical team’s efficacy.
This unparalleled level of customization is critical to our mission: The Human Experience. It enables surgeons to perform groundbreaking, minimally invasive procedures; it helps patients and their families achieve better outcomes; and it maximizes the return-on-investment for the world’s leading neurological institutions.
To make this possible, we need your voice. At every level, and at every stage of our process.
OUTLINING OBJECTIVES IN PHASE 1: CONSULT.
You’ll start by outlining your goals. Are you looking to perform groundbreaking, minimally invasive procedures? What innovations do you want to incorporate in your surgical environment? How can we improve your surgical experience, so you can bring better outcomes to your patients?
Once we’ve outlined your specific objectives, we’ll work with you to determine what technologies and elements of design will bring them to life. We’ll help you decide what hybrid imaging modalities best suit your needs – from Angiography and CT to MRI – while introducing groundbreaking technologies to your surgical environment and harmonizing them with your workflow.
INTEGRATING WORKFLOW IN PHASE 2: DESIGN.
You know your surgical workflow better than anyone else: the nuances of your technique, the challenges you face. Our team of architects and designers will work with you to learn those highly specific details. Then, we’ll leverage that knowledge to design a fully customized surgical environment… one that matches your workflow, keeps your team and your patients safe, and elevates your Human Experience.
BEGINNING EDUCATION IN PHASE 3: CREATE.
Educating your clinical staff on your new surgical environment is essential to safety and operational efficiency. That’s why, rather than waiting for your surgical theatre to be installed, we begin the education process long before final commissioning – often a year or more.
This jump-starts the clinical education process, empowering your team to master the technology and design of your surgical theatre long before it’s ready for use.
ONGOING SERVICE IN PHASE 4: SUPPORT.
Once the theatre is installed, our work has just begun.
Our new Premium Clinical Support service brings a team of clinical applications specialists to your theatre. We have an intimate understanding of your workflow, as well as a deep knowledge of the innovations shaping the industry.
We’ll educate your clinical staff. We’ll consult during procedures. As the industry evolves, we’ll help you introduce new technologies to your surgical theatre – enabling you to perform groundbreaking, minimally invasive procedures and provide better outcomes for your patients.